Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can sound waves tighten your neck? new trial aims to find out

NCT ID NCT07614997

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if the Ulthera System, a non-invasive ultrasound device, can safely improve sagging skin on the lower face, under the chin, and neck. About 218 adults with mild to moderate skin laxity will receive treatment or no treatment, and results will be measured at 90 days. Participants must avoid other facial aesthetic treatments during the study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 218 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Mild to moderate lower face, submental and/or neck laxity, that is amenable to improvement with non-invasive intervention and not severe enough for surgical intervention. * Willing to abstain from all other aesthetic treatments on ANY part of the face, submentum or neck, including but not limited to injectable fillers, implants, neurotoxin, skin peels, laser treatments, surgical treatments, etc. for the clinical investigation's duration. * Willing and able to refrain from chronic use of aspirin, ibuprofen, naproxen, or other nonsteroidal anti-inflammatory drugs (NSAIDs) for 10 to 14 days post-treatment. * Has an adequate understanding of the Chinese language. * Willing and able to comply with protocol requirements. Exclusion Criteria: * Scarring in area(s) to be treated. * Any active implants. * Any metallic implants in area(s) to be treated. * Any open wounds or lesions, including active herpes simplex, in the area(s) to be treated. * Presence of an active systemic or local skin disease, including active, cystic, or severe inflammatory acne in the area(s) to be treated. * History of keloid formation or hypertrophic scarring. * History of the following cosmetic treatments in area(s) to be treated: * Skin-tightening procedure, * Injectable crosslinked hyaluronic acid (HA)/collagen temporary dermal fillers of the lower face, submentum or neck within the past 12 months. * Injectable non-crosslinked HA dermal fillers of the lower face, submentum or neck within the past 6 months. * Injectable semi-permanent/permanent facial fillers * Neurotoxin treatment of the lower face, submentum or neck within the past 6 months. * Liposuction of the lower face, submentum or neck within the last 12 months. * Fat grafting of the lower face, submentum or neck within the last 12 months. * Deoxycholic acid within the last 12 months; and/or * Chemical peeling or dermabrasion treatments within the past 12 months. * Cryolipolysis * Had prior surgery in the lower-facial area and/or neck/submentum or has a permanent implant or graft in the lower-facial area that could interfere with effectiveness assessments. * Has undergone oral surgery in the past 30 days. * Participants who have used isotretinoin or other retinoid medications within 6 months prior to enrollment or have applied topical retinoid-containing medications on the face or neck area within 2 weeks prior to enrollment or planning such treatments during the study period. * Marked facial asymmetry, deep dermal scarring, or thick sebaceous skin in the full face. * Severe solar elastosis. * Facial nerve palsy or history of facial nerve palsy. * Tattoos in the area(s) to be treated (excluding microblading eyebrow). * Current smoker or history of smoking in the last 12 months. * Current daily user of any nicotine-containing products * Is a female of childbearing potential1 and not using medically effective birth control 2 or is pregnant, lactating, or planning to become pregnant during the clinical investigation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cutis laxa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Merz Investigative Site

    RECRUITING

    Beijing, Beijing Municipality, 100034, China

  • Merz Investigative Site

    RECRUITING

    Beijing, Beijing Municipality, 100730, China

  • Merz Investigative Site

    RECRUITING

    Guangzhou, Guangdong, 510317, China

  • Merz Investigative Site

    RECRUITING

    Nanjing, Jiangsu, 210003, China

  • Merz Investigative Site

    RECRUITING

    Xi'an, Shaanxi, 710004, China

  • Merz Investigative Site

    RECRUITING

    Shanghai, Shanghai Municipality, 200040, China

  • Merz Investigative Site

    RECRUITING

    Shanghai, Shanghai Municipality, 200443, China